Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002316687 | SCV000850317 | likely benign | Inborn genetic diseases | 2016-11-09 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV000872965 | SCV001014877 | benign | Mucopolysaccharidosis, MPS-II | 2024-01-21 | criteria provided, single submitter | clinical testing | |
Laboratory of Diagnostic Genome Analysis, |
RCV001572835 | SCV001797832 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001572835 | SCV001967630 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Natera, |
RCV001825440 | SCV002084480 | likely benign | Mucopolysaccharidosis, MPS-III-A | 2021-02-05 | no assertion criteria provided | clinical testing |